ABSTRACT
BACKGROUND
The discovery of Helicobacter pylori (H. pylori) in 1983 is considered one of the most important breakthroughs in the modern gastroenterology [1, 2] . H. pylori is one of the most important public health problems [3] . Globally, it was estimated during 2015 that 4.4 billion persons were infected with H. pylori [1] , and such a prevalence of over 50% of the world's population makes it the commonest global chronic infection. There is a noticeable discrepancy between the prevalence of infection in both developed and developing countries [4] .
H. pylori bacterium is one of the commonest microbiological agents globally, [3, 4] and in the Kingdom of Saudi Arabia (KSA). A recent study in KSA revealed that H. pylori was highly prevalent among Saudi children from Jeddah and Riyadh [5] . Although most of individuals infected with H. pylori are asymptomatic, it colonizes in the gastric mucosa and implicated in causing gastritis, [6] peptic ulcer disease and gastric malignancy (carcinoma and gastric mucosaassociated lymphoid tissue lymphoma) [7] . Hence, H. pylori is classified as a class I carcinogen [4, 8] . It is considered to be the commonest etiological factor of infection-related cancers [9] . Consequently, screening and management of H. pylori is a recommended approach for risk reduction of cancer risk reduction strategy in high-risk populations [4, 9] .
H. pylori was suggested to be associated with extra-gastrointestinal conditions, including those from dermatologic, cardiopulmonary, metabolic and neurologic disorders. H. pylori may be associated also with haematological manifestations as iron deficiency, vitamin B12 deficiency [4, 10, 11] . Furthermore, Idiopathic Thrombocytopenic Purpura (ITP) is the commonest autoimmune hematologic disease that affecting individuals of different ages. H. pylori was suggested to be associated with ITP [12] .
There is inadequate recent studies done to illustrate the current prevalence and the associated factors of H pylori among patients conducted upper GIT endoscopy at King Abdulaziz University Hospital (KAUH). Furthermore, the relationship between H. pylori infection and different haematological parameters was not adequately assessed among Saudi patients, especially in Jeddah. So, such study is needed.
The current study was conducted to determine the epidemiology of Helicobacter pylori, and its relation to the haematological parameters of symptomatic patients who conducted upper gastrointestinal endoscopy at KAUH, Jeddah.
MATERIALS AND METHODS
A retrospective cohort study was conducted during the academic year 2016/2017. All records of the eligible patients who complained from GIT manifestations and conducted upper GIT endoscopy at Gasteoenterology Unit of KAUH during 2015 were assessed. Only cases with samples taken from the gastric mucosa, and examined by the Rapid Urease Test (RUT) were included. The exclusion criteria included patients with malignancy, portal hypertension, liver and kidney diseases. Furthermore, those on nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPI), cytotoxic drugs or steroids were also excluded. In addition, patients below 18 years or patients with immune thrombocytopenia due to any other causes were also excluded. The protocol of our hospital makes the patients to come after 6 months of treatment of H. pylori for follow-up. The results of two sets of Complete Blood Count (CBC) before, and after 6 months of H. pylori treatment were taken from patients' files (initial and follow-up data).
Data was collected through reviewing of medical records. During 2017, telephone interviews were conducted for follow-up of patients (who accepted to participate).
A data collection sheet was constructed (through hospital data extraction sheet, and by patient's interviewing questionnaire). Personal & sociodemographic data were collected. History of chronic medical condition, the indications of conduction of endoscopy and the findings of endoscopy were also taken. Results of RUT were taken. One biopsy was placed immediately on the RUT and examined at 10-minute intervals for the next six hours. If positive result was recorded, a second biopsy with histopathological examination using Giemsa stain was taken. Patients were classified as being H. pyloripositive if any of these assays were positive [13] . Results of two sets of CBC were take; before and after 6 months of treatment of H. pylori. SPSS version 20 was used for the analysis. Descriptive and inferential statistics were conducted. Chi-square and Fisher's exact test were used for the categorical data. Student's tparameteric test, and Mann Whitney nonparamtric test were used for comparing between two means between patients diagnosed with and without H Pylori. Paired-t test was used to compare between the means of haemtological parameters before and after treatment of H. pylori. Odds Ratio (OR) and 95% Confidence Intervals (CI) were calculated. Statistical significance was considered at the level of Pvalue < 0.05.
Ethical Statement
The study followed the ethical standards of "Helsinki declaration". Approval was obtained from the Institutional Review Board (IRB) of KAUH, with a Reference Number of 99-16. All information is confidential. Consent was taken from each participant who accepted to participate in telephone interview.
RESULTS
The flow-diagram for selecting the eligible cases is presented in Figure 1 . The files of a total of 2000 symptomatic persons who conducted upper GIT endoscopy at KAUH during the year 2015 were reviewed. From these file, 312 files fulfilled the eligibility criteria. Out of the 312 eligible patients, 92 (29.5%) had H. pylori positive results, while 220 (70.5%) had negative results using RUT. Table 1 shows that males had a higher prevalence of H. pylori infection (36.6%) compared to females (24.3%), with a statistical significant difference (P < .05). The prevalence was also higher (36.6%) among those aged ≥30 years compared to the younger patients (22.8%). However, there is no statistical difference (P > .05). Similarly, the rate of H. pylori was also higher among smokers, married, diabetics, and hypertensive patients, but without statistical significant differences (P > 0.05). Table 2 demonstrates that the most frequent clinical presentation of H. pylori was epigastric pain (54.3%), followed by each of heartburn and feeling of fullness (26.1% for each), then bloating (21.7%). Vomiting (6.5%), nausea (5.4%), melena (4.3%) and hematemesis (4.3%) were the following complaints.
In the context of endoscopic findings, Table 3 shows presence of significant associations between H. pylori with each of gastritis (OR= 2.15, 95% CI: 1.27-3.66) and gastric ulcer (OR= 4.14, 95% CI: 1.95-8.81). On the other hand, there is no significant association between H. pylori and duodenitis, gastric cancer, gastric polyp, hiatal hernia, esophagitis, Barrett's esophagus, or esophageal varices. [13] . This differences between our and the previous results may be due to differences between the time of conduction of both studies. Decline of H. pylori prevalence overtime can be due to improvements of sanitation and personal hygiene, [15] during the period of 10-years. Similarly, another study from Ethiopia showed some decrease in the prevalence of H. pylori overtime [16] . On the other hand, a recent study from Turkey revealed that H. pylori prevalence between patients who conducted upper GIT endoscopy, with sampling from duodenal biopsy, was higher than our rate (47.9%) [17] . This discrepancy may be due to the differences between countries, or due to type of diagnostic test, type patients or the sample size taken. However, a lower sero-prevalence (about 15%) of H. pylori was reported from two studies done among normal adults from Australia [18] and Indonesia [19] . The cause of such difference between our study and the two previous studies may be because our study was a hospital-based study done among symptomatic patients who complained from GIT symptoms and conducted a diagnostic endoscopy, while the earlier studies were community-based studies that done among normal persons. This may be also due to differences between countries. There is a debate regarding the role of gender in infection with H. pylori [16] . In the present study, males had a significantly higher rate of infection with H. pylori compared to females, which agrees with a 5-year trend of the agent from Ethiopia [16] and with a study from India [20] . On the other hand, a recent study, 2018, reported that the prevalence of H. pylori was higher among females [6] . These gender differences in rate of infection may be attributed to the variations between countries, rates of exposure, and the susceptibility to infection among both genders, samples, and the diagnostic method.
In our study, older patients had a higher prevalence of H. pylori than the younger (P >0 .05), which coincides with results from Indonesia [19] and the USA [21] . Furthermore, results of the current study reported absence of significant association between smoking and H. pylori, which coincides with result from a Pakistani study [3] .
In the current study, the commonest complaints of patients with H. pylori infection was Epigastric pain (54.3%) which is in line with results of a study from Uganda [22] . Similarly, findings from another recent Ethiopian study, 2018, revealed that H. pylori was associated with upper GIT complaints such as Epigastric burning/pain [23] .
In the present study, associations were found between H. pylori and each of gastritis and gastric ulcer, which agree with the results from Uganda [22] . These findings occurred because infection with H. pylori can increase the "proinflammatory cytokine gene expressions in gastric epithelial cells by stimulation of NF-kB signalling" which may be implicated in causing gastritis and other gastric complications [7] . However, our results didn't find an association between H. pylori and gastric carcinoma, which may be attributed to small number of cases. It was estimated that only 1 -3% of H pylori infected persons can cause gastric carcinoma [9] .
The current study demonstrated absence of statistical association between H. pylori and each of thrombocytopenia, anaemia or other haematological parameters. Similarly, a study done among pregnant women from Khartoum, Sudan, also reported absence of associations between H. pylori infection and anaemia and thrombocytopenia [24] . Similar finding was obtained from another study from Mexico [25] . The USA study [21] also concluded that H. pylori was not implicated in the pathogenesis of ITP. On the other hand, a study done among 30 patients with ITP and equal number of controls found presence of association between it and H. pylori [26] . This discrepancy between studies may be attributed to differences between sample sizes, or study populations. . The cause of such discrepancy between the current and previous studies may be attributed to differences between populations, sample size or the received treatment.
As our study is retrospective study, it has some limitations of the incompleteness of some data. 
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